Concepts (320)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spirituality | 40 | 2024 | 430 | 9.760 |
Why?
|
Palliative Care | 49 | 2024 | 3640 | 5.110 |
Why?
|
Radiation Oncology | 13 | 2024 | 572 | 3.570 |
Why?
|
Terminal Care | 30 | 2024 | 1769 | 3.160 |
Why?
|
Religion | 11 | 2022 | 376 | 2.920 |
Why?
|
Religion and Medicine | 13 | 2018 | 161 | 2.290 |
Why?
|
Spiritual Therapies | 5 | 2023 | 60 | 2.150 |
Why?
|
Neoplasms | 53 | 2024 | 22350 | 2.080 |
Why?
|
Spinal Neoplasms | 13 | 2024 | 714 | 1.990 |
Why?
|
Clergy | 9 | 2021 | 79 | 1.740 |
Why?
|
Bone Neoplasms | 6 | 2024 | 2561 | 1.160 |
Why?
|
Nurses | 6 | 2015 | 2503 | 1.140 |
Why?
|
Pastoral Care | 5 | 2018 | 72 | 0.860 |
Why?
|
Attitude of Health Personnel | 10 | 2016 | 3927 | 0.820 |
Why?
|
Morals | 4 | 2019 | 288 | 0.820 |
Why?
|
Life Expectancy | 4 | 2013 | 1248 | 0.810 |
Why?
|
Spinal Cord Compression | 5 | 2019 | 234 | 0.810 |
Why?
|
Adaptation, Psychological | 13 | 2019 | 2662 | 0.800 |
Why?
|
Terminally Ill | 8 | 2024 | 240 | 0.770 |
Why?
|
Physicians | 9 | 2019 | 4591 | 0.710 |
Why?
|
Psychometrics | 4 | 2021 | 3060 | 0.710 |
Why?
|
Hospice Care | 7 | 2019 | 678 | 0.700 |
Why?
|
Quality of Life | 22 | 2024 | 13476 | 0.690 |
Why?
|
Spinal Fractures | 2 | 2018 | 702 | 0.670 |
Why?
|
Biomedical Research | 4 | 2020 | 3459 | 0.660 |
Why?
|
Religion and Psychology | 6 | 2019 | 180 | 0.660 |
Why?
|
Hospices | 3 | 2019 | 245 | 0.650 |
Why?
|
Health | 1 | 2022 | 396 | 0.650 |
Why?
|
Joint Instability | 2 | 2018 | 803 | 0.640 |
Why?
|
Lung Neoplasms | 9 | 2022 | 13489 | 0.620 |
Why?
|
Research Personnel | 3 | 2020 | 589 | 0.610 |
Why?
|
Decision Making | 6 | 2021 | 3951 | 0.560 |
Why?
|
Advance Care Planning | 8 | 2017 | 698 | 0.550 |
Why?
|
Attitude to Death | 7 | 2015 | 400 | 0.550 |
Why?
|
Disease | 1 | 2022 | 675 | 0.550 |
Why?
|
Health Personnel | 5 | 2022 | 3384 | 0.530 |
Why?
|
Life Support Care | 2 | 2017 | 226 | 0.510 |
Why?
|
Radiotherapy | 5 | 2018 | 1497 | 0.500 |
Why?
|
Medical Oncology | 4 | 2018 | 2340 | 0.490 |
Why?
|
Research Report | 1 | 2018 | 367 | 0.470 |
Why?
|
Cancer Care Facilities | 4 | 2016 | 428 | 0.460 |
Why?
|
Proxy | 1 | 2015 | 150 | 0.460 |
Why?
|
Ossification, Heterotopic | 2 | 2007 | 240 | 0.450 |
Why?
|
Humans | 122 | 2024 | 766812 | 0.430 |
Why?
|
Faculty | 2 | 2016 | 383 | 0.410 |
Why?
|
Middle Aged | 60 | 2024 | 223267 | 0.390 |
Why?
|
Professional-Family Relations | 1 | 2015 | 500 | 0.370 |
Why?
|
Male | 72 | 2024 | 364154 | 0.370 |
Why?
|
Faith Healing | 1 | 2011 | 25 | 0.370 |
Why?
|
Interviews as Topic | 11 | 2021 | 2741 | 0.370 |
Why?
|
Spinal Diseases | 1 | 2015 | 561 | 0.340 |
Why?
|
Female | 69 | 2024 | 396532 | 0.340 |
Why?
|
Education, Medical | 3 | 2016 | 1744 | 0.330 |
Why?
|
Schools, Medical | 2 | 2016 | 882 | 0.330 |
Why?
|
Critical Care | 3 | 2017 | 2714 | 0.320 |
Why?
|
Death | 3 | 2023 | 685 | 0.310 |
Why?
|
Attitude to Health | 2 | 2019 | 2021 | 0.300 |
Why?
|
Critical Illness | 4 | 2018 | 2750 | 0.280 |
Why?
|
Periodicals as Topic | 1 | 2018 | 1463 | 0.270 |
Why?
|
Patient Selection | 2 | 2020 | 4252 | 0.270 |
Why?
|
Qualitative Research | 11 | 2022 | 3138 | 0.270 |
Why?
|
Radiotherapy, Intensity-Modulated | 6 | 2015 | 798 | 0.270 |
Why?
|
Students, Medical | 3 | 2016 | 1962 | 0.260 |
Why?
|
Radiotherapy Dosage | 6 | 2018 | 2916 | 0.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 4056 | 0.250 |
Why?
|
Aged | 38 | 2024 | 171344 | 0.250 |
Why?
|
Veterans | 1 | 2019 | 2667 | 0.240 |
Why?
|
Physician-Patient Relations | 8 | 2021 | 3266 | 0.240 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1445 | 0.240 |
Why?
|
United States | 20 | 2024 | 72945 | 0.230 |
Why?
|
Focus Groups | 8 | 2021 | 1459 | 0.230 |
Why?
|
Prospective Studies | 19 | 2022 | 54872 | 0.230 |
Why?
|
Faculty, Medical | 2 | 2016 | 1226 | 0.220 |
Why?
|
Hip Prosthesis | 2 | 2007 | 924 | 0.220 |
Why?
|
Health Care Surveys | 4 | 2017 | 2425 | 0.220 |
Why?
|
Cohort Studies | 10 | 2022 | 41706 | 0.220 |
Why?
|
Pain | 5 | 2024 | 5098 | 0.210 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7430 | 0.210 |
Why?
|
Radiation Protection | 1 | 2007 | 425 | 0.210 |
Why?
|
Patient Care Team | 4 | 2023 | 2519 | 0.200 |
Why?
|
Neoplasm Metastasis | 4 | 2019 | 4892 | 0.200 |
Why?
|
Patient Preference | 4 | 2021 | 946 | 0.200 |
Why?
|
Internship and Residency | 2 | 2017 | 5943 | 0.200 |
Why?
|
Nurse-Patient Relations | 2 | 2014 | 101 | 0.200 |
Why?
|
Retrospective Studies | 21 | 2024 | 81657 | 0.200 |
Why?
|
Health Care Costs | 2 | 2014 | 3240 | 0.190 |
Why?
|
Adult | 26 | 2024 | 223305 | 0.190 |
Why?
|
Advance Directives | 2 | 2014 | 249 | 0.180 |
Why?
|
Boston | 6 | 2013 | 9346 | 0.180 |
Why?
|
Brain Neoplasms | 2 | 2019 | 9101 | 0.180 |
Why?
|
Clinical Competence | 1 | 2016 | 4858 | 0.180 |
Why?
|
Career Choice | 1 | 2007 | 768 | 0.170 |
Why?
|
Perception | 3 | 2015 | 1204 | 0.170 |
Why?
|
Public Health | 2 | 2024 | 2680 | 0.170 |
Why?
|
Radiosurgery | 2 | 2022 | 1330 | 0.170 |
Why?
|
Cultural Characteristics | 2 | 2019 | 250 | 0.160 |
Why?
|
Analysis of Variance | 3 | 2015 | 6214 | 0.160 |
Why?
|
Teaching | 1 | 2007 | 1171 | 0.160 |
Why?
|
Models, Statistical | 1 | 2013 | 5092 | 0.160 |
Why?
|
Bone Diseases | 1 | 2022 | 412 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2012 | 4050 | 0.150 |
Why?
|
Referral and Consultation | 3 | 2020 | 3618 | 0.150 |
Why?
|
International Agencies | 1 | 2019 | 244 | 0.150 |
Why?
|
Patient Satisfaction | 1 | 2011 | 3485 | 0.150 |
Why?
|
Fractures, Spontaneous | 1 | 2019 | 230 | 0.150 |
Why?
|
Aged, 80 and over | 10 | 2020 | 59548 | 0.140 |
Why?
|
Goals | 1 | 2022 | 717 | 0.140 |
Why?
|
Epidemiologic Research Design | 1 | 2020 | 368 | 0.140 |
Why?
|
Christianity | 1 | 2017 | 53 | 0.140 |
Why?
|
Socialization | 1 | 2016 | 88 | 0.130 |
Why?
|
Lymphopenia | 1 | 2018 | 300 | 0.130 |
Why?
|
Severity of Illness Index | 6 | 2021 | 15912 | 0.130 |
Why?
|
Chaplaincy Service, Hospital | 1 | 2015 | 22 | 0.120 |
Why?
|
Logistic Models | 6 | 2014 | 13276 | 0.120 |
Why?
|
Hospitalization | 2 | 2015 | 10816 | 0.120 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20146 | 0.120 |
Why?
|
Spine | 2 | 2019 | 1134 | 0.120 |
Why?
|
Spiritualism | 1 | 2014 | 18 | 0.110 |
Why?
|
Self-Assessment | 1 | 2016 | 400 | 0.110 |
Why?
|
Critical Pathways | 1 | 2017 | 475 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2019 | 904 | 0.110 |
Why?
|
Survival Analysis | 6 | 2024 | 10101 | 0.110 |
Why?
|
Quality of Health Care | 3 | 2013 | 4306 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2018 | 488 | 0.110 |
Why?
|
Medicine | 2 | 2021 | 944 | 0.110 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7841 | 0.110 |
Why?
|
Prognosis | 8 | 2022 | 29959 | 0.110 |
Why?
|
Massachusetts | 2 | 2017 | 8890 | 0.110 |
Why?
|
Brachytherapy | 1 | 2020 | 1221 | 0.100 |
Why?
|
Minority Groups | 1 | 2020 | 1208 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26309 | 0.100 |
Why?
|
Inpatients | 2 | 2021 | 2566 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2017 | 811 | 0.100 |
Why?
|
Professional-Patient Relations | 1 | 2017 | 724 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2012 | 1788 | 0.100 |
Why?
|
Trust | 1 | 2017 | 532 | 0.100 |
Why?
|
Sampling Studies | 1 | 2013 | 614 | 0.100 |
Why?
|
Head and Neck Neoplasms | 3 | 2010 | 2930 | 0.100 |
Why?
|
Back Pain | 1 | 2015 | 547 | 0.090 |
Why?
|
Cooperative Behavior | 2 | 2015 | 1512 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 830 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 5389 | 0.090 |
Why?
|
Societies, Medical | 3 | 2024 | 3957 | 0.090 |
Why?
|
Seminoma | 1 | 2012 | 136 | 0.090 |
Why?
|
Self Efficacy | 1 | 2015 | 643 | 0.090 |
Why?
|
Pain Measurement | 1 | 2020 | 3576 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2022 | 65286 | 0.090 |
Why?
|
Human papillomavirus 16 | 1 | 2012 | 268 | 0.090 |
Why?
|
Postoperative Period | 1 | 2015 | 1824 | 0.090 |
Why?
|
Linear Models | 2 | 2012 | 5873 | 0.080 |
Why?
|
Spinal Fusion | 1 | 2019 | 1307 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2017 | 1540 | 0.080 |
Why?
|
Mortality | 2 | 2019 | 2908 | 0.080 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2010 | 102 | 0.080 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5513 | 0.080 |
Why?
|
Communication | 3 | 2021 | 3905 | 0.080 |
Why?
|
Resuscitation Orders | 4 | 2014 | 271 | 0.080 |
Why?
|
Curriculum | 3 | 2018 | 3783 | 0.080 |
Why?
|
Social Perception | 1 | 2012 | 435 | 0.080 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2015 | 1673 | 0.080 |
Why?
|
Caregivers | 3 | 2010 | 2303 | 0.080 |
Why?
|
Hospitals, Rural | 1 | 2010 | 174 | 0.080 |
Why?
|
Home Care Services | 1 | 2015 | 659 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2015 | 1274 | 0.080 |
Why?
|
Movement | 1 | 2015 | 1468 | 0.080 |
Why?
|
Hospitals, Urban | 1 | 2010 | 494 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2325 | 0.070 |
Why?
|
Sex Factors | 2 | 2019 | 10619 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2921 | 0.070 |
Why?
|
Orthopedic Procedures | 1 | 2018 | 1279 | 0.070 |
Why?
|
Watchful Waiting | 1 | 2012 | 492 | 0.070 |
Why?
|
Health Services Research | 1 | 2015 | 1811 | 0.070 |
Why?
|
Dementia | 1 | 2022 | 2741 | 0.070 |
Why?
|
Propensity Score | 1 | 2015 | 1972 | 0.070 |
Why?
|
Lymphocyte Count | 2 | 2019 | 794 | 0.070 |
Why?
|
Salivary Gland Neoplasms | 1 | 2010 | 306 | 0.070 |
Why?
|
Models, Theoretical | 2 | 2015 | 3563 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2504 | 0.070 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2012 | 492 | 0.070 |
Why?
|
Developing Countries | 1 | 2019 | 2912 | 0.070 |
Why?
|
Neoplasms, Second Primary | 2 | 2012 | 1062 | 0.060 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2007 | 1417 | 0.060 |
Why?
|
Indomethacin | 1 | 2006 | 323 | 0.060 |
Why?
|
Mouth Neoplasms | 1 | 2011 | 597 | 0.060 |
Why?
|
Prevalence | 3 | 2014 | 15835 | 0.060 |
Why?
|
Testicular Neoplasms | 1 | 2012 | 806 | 0.060 |
Why?
|
Hospitals, Teaching | 1 | 2010 | 1156 | 0.060 |
Why?
|
Neoplasm Staging | 5 | 2012 | 11218 | 0.060 |
Why?
|
SEER Program | 1 | 2010 | 1444 | 0.060 |
Why?
|
Career Mobility | 1 | 2007 | 262 | 0.060 |
Why?
|
Health Promotion | 1 | 2016 | 2209 | 0.060 |
Why?
|
Bereavement | 1 | 2008 | 309 | 0.060 |
Why?
|
Health Status | 1 | 2017 | 4087 | 0.060 |
Why?
|
Social Support | 1 | 2014 | 2191 | 0.060 |
Why?
|
Suicidal Ideation | 1 | 2014 | 1467 | 0.050 |
Why?
|
Algorithms | 1 | 2024 | 14073 | 0.050 |
Why?
|
Risk Assessment | 3 | 2018 | 24299 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4526 | 0.050 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2010 | 1374 | 0.050 |
Why?
|
Health Status Indicators | 1 | 2008 | 968 | 0.050 |
Why?
|
Hodgkin Disease | 1 | 2010 | 1384 | 0.050 |
Why?
|
Dermatitis | 2 | 2017 | 203 | 0.050 |
Why?
|
Mental Health | 3 | 2017 | 3269 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 10384 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 3186 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8728 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3411 | 0.050 |
Why?
|
Patient Participation | 2 | 2021 | 1445 | 0.050 |
Why?
|
Prosthesis Failure | 1 | 2007 | 1208 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2018 | 9407 | 0.050 |
Why?
|
Mentors | 1 | 2007 | 671 | 0.050 |
Why?
|
Immunotherapy | 1 | 2017 | 4747 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4903 | 0.040 |
Why?
|
Xerostomia | 2 | 2010 | 94 | 0.040 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13644 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4282 | 0.040 |
Why?
|
Treatment Failure | 2 | 2019 | 2659 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2012 | 1639 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2024 | 642 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 11876 | 0.040 |
Why?
|
Area Under Curve | 1 | 2024 | 1639 | 0.040 |
Why?
|
England | 1 | 2021 | 533 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6853 | 0.040 |
Why?
|
Young Adult | 3 | 2018 | 59939 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8616 | 0.040 |
Why?
|
Carboplatin | 2 | 2012 | 790 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5702 | 0.040 |
Why?
|
Health Surveys | 2 | 2018 | 4055 | 0.040 |
Why?
|
Arthrodesis | 1 | 2019 | 187 | 0.040 |
Why?
|
Multiple Myeloma | 2 | 2019 | 5193 | 0.040 |
Why?
|
Risk Factors | 4 | 2019 | 74889 | 0.040 |
Why?
|
Taxoids | 2 | 2012 | 665 | 0.040 |
Why?
|
Incidence | 2 | 2018 | 21527 | 0.030 |
Why?
|
Cultural Diversity | 1 | 2021 | 370 | 0.030 |
Why?
|
Systems Integration | 1 | 2019 | 425 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2017 | 8540 | 0.030 |
Why?
|
Platelet Count | 1 | 2019 | 784 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 792 | 0.030 |
Why?
|
Disease Progression | 2 | 2019 | 13642 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2270 | 0.030 |
Why?
|
Equipment and Supplies | 1 | 2019 | 273 | 0.030 |
Why?
|
Specialties, Surgical | 1 | 2021 | 391 | 0.030 |
Why?
|
Kyphoplasty | 1 | 2016 | 45 | 0.030 |
Why?
|
ROC Curve | 1 | 2024 | 3621 | 0.030 |
Why?
|
PubMed | 1 | 2016 | 129 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39312 | 0.030 |
Why?
|
Personhood | 1 | 2015 | 31 | 0.030 |
Why?
|
Fluorouracil | 2 | 2012 | 1652 | 0.030 |
Why?
|
Health Care Rationing | 1 | 2019 | 435 | 0.030 |
Why?
|
Vertebroplasty | 1 | 2016 | 78 | 0.030 |
Why?
|
Right to Die | 1 | 2014 | 34 | 0.030 |
Why?
|
Cisplatin | 2 | 2012 | 1656 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2017 | 392 | 0.030 |
Why?
|
Immobilization | 1 | 2015 | 227 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2019 | 603 | 0.030 |
Why?
|
Evidence-Based Medicine | 2 | 2016 | 3692 | 0.030 |
Why?
|
South Africa | 1 | 2020 | 1873 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 3230 | 0.030 |
Why?
|
Femur | 1 | 2020 | 1318 | 0.030 |
Why?
|
Allied Health Personnel | 1 | 2015 | 156 | 0.030 |
Why?
|
Paclitaxel | 2 | 2012 | 1728 | 0.030 |
Why?
|
Hospitals | 2 | 2021 | 3885 | 0.030 |
Why?
|
Survival Rate | 2 | 2018 | 12826 | 0.030 |
Why?
|
Organs at Risk | 1 | 2015 | 367 | 0.030 |
Why?
|
Personal Autonomy | 1 | 2015 | 316 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21162 | 0.020 |
Why?
|
Empathy | 1 | 2016 | 474 | 0.020 |
Why?
|
Health Policy | 1 | 2024 | 2697 | 0.020 |
Why?
|
Diphosphonates | 1 | 2016 | 625 | 0.020 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2015 | 447 | 0.020 |
Why?
|
Lymphoma | 1 | 2019 | 1899 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2019 | 1790 | 0.020 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2010 | 91 | 0.020 |
Why?
|
Orchiectomy | 1 | 2012 | 466 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2012 | 476 | 0.020 |
Why?
|
Mucositis | 1 | 2010 | 107 | 0.020 |
Why?
|
Esophagitis | 1 | 2010 | 164 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 932 | 0.020 |
Why?
|
Albumins | 1 | 2012 | 578 | 0.020 |
Why?
|
Esophageal Stenosis | 1 | 2010 | 196 | 0.020 |
Why?
|
Retreatment | 1 | 2010 | 598 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12064 | 0.020 |
Why?
|
Medical Audit | 1 | 2010 | 454 | 0.020 |
Why?
|
Colitis | 1 | 2017 | 1238 | 0.020 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2010 | 262 | 0.020 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 542 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11094 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 1404 | 0.020 |
Why?
|
Standard of Care | 1 | 2012 | 569 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18397 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2015 | 949 | 0.020 |
Why?
|
Outpatients | 1 | 2015 | 1596 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2010 | 993 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2009 | 896 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2533 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9602 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2017 | 2077 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2703 | 0.020 |
Why?
|
Neutrophils | 1 | 2018 | 3782 | 0.020 |
Why?
|
Postoperative Care | 1 | 2012 | 1480 | 0.020 |
Why?
|
Self Report | 1 | 2016 | 3771 | 0.010 |
Why?
|
Withholding Treatment | 1 | 2009 | 619 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2476 | 0.010 |
Why?
|
Resuscitation | 1 | 2008 | 681 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 2012 | 9244 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4356 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 2009 | 14762 | 0.010 |
Why?
|
Physician's Role | 1 | 2008 | 925 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6514 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 88902 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12536 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10745 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9661 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2010 | 3799 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 5330 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36459 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42577 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2010 | 6359 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15425 | 0.010 |
Why?
|
Child | 1 | 2017 | 80670 | 0.000 |
Why?
|
Concepts
(320)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(110)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_